A Randomized Phase II, Open-Label Multicenter Trial of Panobinostat Monotherapy in Women With HER2 Positive Locally Recurrent or Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Panobinostat (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 04 Jul 2012 Planned number of patients changed from 132 to 140 and additional trial locations (France, United Kingdom) added as reported by European Clinical Trials Database.
- 21 May 2010 Actual patient number (4) added as reported by ClinicalTrials.gov.
- 21 May 2010 Planned end date changed from 1 Nov 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov.